Galderma R&d
Clinical trials sponsored by Galderma R&d, explained in plain language.
-
New eczema drug tested in 1,000 patients – hope for severe itch relief
Disease control Recruiting nowThis study is testing a medication called nemolizumab in 1,000 adolescents and adults with moderate-to-severe atopic dermatitis (eczema). The goal is to see how well it works in real-world settings, focusing on reducing itch and clearing skin over 6 months. Participants will rece…
Sponsor: Galderma R&D • Aim: Disease control
Last updated Jun 09, 2026 12:08 UTC
-
Promising new treatment for rare skin disease enters Mid-Stage trial
Disease control Recruiting nowThis study tests a drug called nemolizumab in adults with systemic sclerosis, a disease that causes skin to harden and tighten. The main goal is to see if the drug can reduce skin thickness and find the best dose. About 162 participants will receive either nemolizumab or a placeb…
Phase: PHASE2 • Sponsor: Galderma R&D • Aim: Disease control
Last updated Jun 08, 2026 13:08 UTC
-
New acne cream shows promise in chinese trial
Symptom relief Recruiting nowThis study tests a cream called trifarotene on Chinese people aged 9 and older with moderate acne on the face and upper body. About 561 participants will apply the cream or a placebo daily for 12 weeks. The goal is to see if the cream reduces acne lesions and improves skin appear…
Phase: PHASE3 • Sponsor: Galderma R&D • Aim: Symptom relief
Last updated Jun 09, 2026 12:07 UTC
-
New Real-World study tests nemolizumab for chronic itch condition
Symptom relief Recruiting nowThis study looks at how well the drug nemolizumab works for adults with moderate-to-severe prurigo nodularis, a skin condition that causes intense itching and bumps. Researchers will track 600 participants over 6 months in real-world clinics, measuring itch severity and skin lesi…
Sponsor: Galderma R&D • Aim: Symptom relief
Last updated Jun 09, 2026 12:07 UTC
-
Can a filler boost your Skin's look? new study tests restylane
Symptom relief Recruiting nowThis study tests if Restylane Skinboosters Vital Lidocaine can improve facial skin quality, like reducing fine lines. About 171 Chinese adults will either get the treatment or no treatment. The goal is to see if the treatment makes a visible difference in skin smoothness.
Phase: NA • Sponsor: Galderma R&D • Aim: Symptom relief
Last updated Jun 08, 2026 13:18 UTC
-
New hope for mystery itch: drug trial targets chronic pruritus
Symptom relief Recruiting nowThis study tests a drug called nemolizumab in 50 adults who have had chronic itching for at least 6 months with no known cause. The goal is to see how the drug moves through the body and how well it reduces itching over 16 weeks. Participants must be 18 or older and have normal-a…
Phase: PHASE2 • Sponsor: Galderma R&D • Aim: Symptom relief
Last updated Jun 08, 2026 13:05 UTC
-
Scientists peek under the skin to see how sculptra works
Knowledge-focused Recruiting nowThis study looks at how the skin changes after treatment with Sculptra, a biostimulator for cheek wrinkles. Researchers will use special cameras to take detailed pictures of the skin before and after treatment. The goal is to understand the structural changes, not to provide trea…
Phase: NA • Sponsor: Galderma R&D • Aim: Knowledge-focused
Last updated Jun 01, 2026 18:02 UTC
-
Can a collagen booster change menopausal skin at the cellular level?
Knowledge-focused Recruiting nowThis study looks at how a collagen-stimulating treatment called poly L-lactic acid (PLLA) affects skin proteins in menopausal women with moderate to severe cheek wrinkles. Forty women will receive the treatment, and small skin samples will be taken to measure changes. The goal is…
Phase: NA • Sponsor: Galderma R&D • Aim: Knowledge-focused
Last updated May 27, 2026 12:02 UTC